TheJournal.ie uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Click here to find out more »
Dublin: 11 °C Saturday 25 May, 2013

Oireachtas agenda: Generic drugs and insurance for flood victims

It’s a light day in the Oireachtas today, with only two committee meetings being held.

Junior health minister Alex White (right) will attend the Health sub-committee today to deal with possible changes to new laws on generic drugs.
Junior health minister Alex White (right) will attend the Health sub-committee today to deal with possible changes to new laws on generic drugs.
Image: Laura Hutton/Photocall Ireland

WHAT ARE OUR politicians doing in the halls of Leinster House?

TheJournal.ie lets you know with our guide to what’s coming up to the Dáil, Seanad and various Oireachtas committees today.

As it happens, however, today’s agenda is a light one – with most of our ministers still abroad on St Patrick’s Day trade missions.

As a result there are only two committee meetings being held today; the main business in the Dáil and Seanad resumes tomorrow.

  • At 2:15pm the committee on the Environment, Culture and the Gaeltacht discusses some of the problems experienced by households in flood-prone areas in getting household insurance. Representatives from the Irish Insurance Federation will be on hand to discuss why insurers feel they cannot cover properties in some areas. (Watch here.)
  • At 3:30pm the Health sub-committee will get its teeth into legislation which could, potentially, save millions for the taxpayer – debating amendments to a Bill which would introduce new ‘reference pricing’ for drugs, and define a list of drugs which a pharmacist can administer in place of another if it’s cheaper to do so. The idea is that a branded drug prescribed by a doctor can be replaced with a cheaper one that has the same chemical make-up and effect. (Watch here.)

Read: Head of HSE drug-buying programme: ‘It’s difficult to defend current prices’

Read next:

Comments (5 Comments)

  • Reference drug pricing has consistently been proven to be inefficient and has in the majority of cases resulted in reductions in population health. The pharmaceutical companies can withhold release and supply of drugs into markets where the return to them is not deemed enough. Reference pricing is not the ‘holy grail’ it is often presented as in relation to escalating drug budgets.
    Just ask the Greeks! Not only did pharmaceutical companies withdraw drugs from the Greek market they withdrew their jobs and any presence they had in the Greek market.
    Reference pricing is outdated and a more innovative method of cost containment is required. We are about 20yrs too late to the reference pricing party!

    Reply
  • Fleeced again by big business, what’ new??

    Reply
  • I recently bough a prescription drug in Portugal that was …………………. wait for it………………….10% of the cost of the same drug in Ireland! A generic Lipitor is €7.50 in Portugal, in Ireland €57 for the original.

    Reply
  • Very busy day lads.

    Reply

Add New Comment